Olivier Danos

Company: REGENXBIO

Job title: Chief Scientific Officer

Seminars:

Q&A Panel Discussion: Delivery 11:20 am

• Comparing different patient populations for different indications and their suitability for different delivery routes • Discussing biodistribution vs invasive procedures for delivery to the brain • Exploring the risk/benefit of different routes of administration, is the data translatable? • Introducing technology advances for the delivery devices, where is there room for improvement?Read more

day: Day Two

Safety & Efficacy of Intra-Cisternal Administration of AAV Vectors 10:20 am

• Evaluating the intra-cisternal route: pros and cons • Exploring preclinical studies of toxicity and biodistribution • Discussing clinical validationRead more

day: Day Two